Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy vs Doxorubicin-Cisplatin in Advanced Endometrial Carcinoma
NCT00002493Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- May 1992
- Primary completion
- Apr 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of doxorubicin and cisplatin in endometrial carcinoma (2 arms), sponsored by GOG Foundation. Primary endpoints: Overall Survival and Progression-Free Interval. Started May 1992; status: completed.
02
Drugs
doxorubicincisplatin
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00002493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002493.